Cargando…
Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the DMPK gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218431/ https://www.ncbi.nlm.nih.gov/pubmed/30425655 http://dx.doi.org/10.3389/fphys.2018.01532 |
_version_ | 1783368449401028608 |
---|---|
author | Hintze, Stefan Knaier, Lisa Limmer, Sarah Schoser, Benedikt Meinke, Peter |
author_facet | Hintze, Stefan Knaier, Lisa Limmer, Sarah Schoser, Benedikt Meinke, Peter |
author_sort | Hintze, Stefan |
collection | PubMed |
description | Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the DMPK gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a general splicing defect. We observed nuclear envelope (NE) alterations in DM1 primary myoblasts. These included invaginations of the NE as well as an altered composition of the nuclear lamina. Specifically, we investigated NE transmembrane proteins (NETs) in DM1 primary myoblasts, staining to determine if their distribution was altered compared to controls and if this could contribute to these structural defects. We also tested the expression of these NETs in muscle and how localization changes in the DM1 primary myoblasts undergoing differentiation in vitro to myotubes. We found no changes in the localization of the tested NETs, but most tended to exhibit reduced expression with increasing DMPK-repeat length. Nonetheless, the DM1 patient expression range was within the expression range of the controls. Additionally, we found a down-regulation of the possible nesprin 1 giant isoform in DM1 primary myoblasts which could contribute to the increased NE invaginations. Thus, nesprin 1 may be an interesting target for further investigation in DM1 disease pathology. |
format | Online Article Text |
id | pubmed-6218431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62184312018-11-13 Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 Hintze, Stefan Knaier, Lisa Limmer, Sarah Schoser, Benedikt Meinke, Peter Front Physiol Physiology Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the DMPK gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a general splicing defect. We observed nuclear envelope (NE) alterations in DM1 primary myoblasts. These included invaginations of the NE as well as an altered composition of the nuclear lamina. Specifically, we investigated NE transmembrane proteins (NETs) in DM1 primary myoblasts, staining to determine if their distribution was altered compared to controls and if this could contribute to these structural defects. We also tested the expression of these NETs in muscle and how localization changes in the DM1 primary myoblasts undergoing differentiation in vitro to myotubes. We found no changes in the localization of the tested NETs, but most tended to exhibit reduced expression with increasing DMPK-repeat length. Nonetheless, the DM1 patient expression range was within the expression range of the controls. Additionally, we found a down-regulation of the possible nesprin 1 giant isoform in DM1 primary myoblasts which could contribute to the increased NE invaginations. Thus, nesprin 1 may be an interesting target for further investigation in DM1 disease pathology. Frontiers Media S.A. 2018-10-30 /pmc/articles/PMC6218431/ /pubmed/30425655 http://dx.doi.org/10.3389/fphys.2018.01532 Text en Copyright © 2018 Hintze, Knaier, Limmer, Schoser and Meinke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Hintze, Stefan Knaier, Lisa Limmer, Sarah Schoser, Benedikt Meinke, Peter Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
title | Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
title_full | Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
title_fullStr | Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
title_full_unstemmed | Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
title_short | Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
title_sort | nuclear envelope transmembrane proteins in myotonic dystrophy type 1 |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218431/ https://www.ncbi.nlm.nih.gov/pubmed/30425655 http://dx.doi.org/10.3389/fphys.2018.01532 |
work_keys_str_mv | AT hintzestefan nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1 AT knaierlisa nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1 AT limmersarah nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1 AT schoserbenedikt nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1 AT meinkepeter nuclearenvelopetransmembraneproteinsinmyotonicdystrophytype1 |